These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32236960)

  • 41. Translation of pharmacogenomic drug labels into the clinic. Current problems.
    Ingelman-Sundberg M
    Pharmacol Res; 2020 Mar; 153():104620. PubMed ID: 31899313
    [No Abstract]   [Full Text] [Related]  

  • 42. An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
    Miñarro-Giménez JA; Blagec K; Boyce RD; Adlassnig KP; Samwald M
    PLoS One; 2014; 9(5):e93769. PubMed ID: 24787444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 44. Disease-drug database for pharmacogenomic-based prescribing.
    Hussain S; Kenigsberg BB; Danahey K; Lee YM; Galecki PM; Ratain MJ; O'Donnell PH
    Clin Pharmacol Ther; 2016 Aug; 100(2):179-90. PubMed ID: 26940584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants.
    Pandi MT; Koromina M; Tsafaridis I; Patsilinakos S; Christoforou E; van der Spek PJ; Patrinos GP
    Hum Genomics; 2021 Aug; 15(1):51. PubMed ID: 34372920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.
    Dong OM; Wiltshire T
    Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase.
    Nguyen KA; Patel H; Haggstrom DA; Zillich AJ; Imperiale TF; Russ AL
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):194. PubMed ID: 31623616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
    Cavallari LH; Lee CR; Beitelshees AL; Cooper-DeHoff RM; Duarte JD; Voora D; Kimmel SE; McDonough CW; Gong Y; Dave CV; Pratt VM; Alestock TD; Anderson RD; Alsip J; Ardati AK; Brott BC; Brown L; Chumnumwat S; Clare-Salzler MJ; Coons JC; Denny JC; Dillon C; Elsey AR; Hamadeh IS; Harada S; Hillegass WB; Hines L; Horenstein RB; Howell LA; Jeng LJB; Kelemen MD; Lee YM; Magvanjav O; Montasser M; Nelson DR; Nutescu EA; Nwaba DC; Pakyz RE; Palmer K; Peterson JF; Pollin TI; Quinn AH; Robinson SW; Schub J; Skaar TC; Smith DM; Sriramoju VB; Starostik P; Stys TP; Stevenson JM; Varunok N; Vesely MR; Wake DT; Weck KE; Weitzel KW; Wilke RA; Willig J; Zhao RY; Kreutz RP; Stouffer GA; Empey PE; Limdi NA; Shuldiner AR; Winterstein AG; Johnson JA;
    JACC Cardiovasc Interv; 2018 Jan; 11(2):181-191. PubMed ID: 29102571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Review of the Pharmacogenomics of Direct Oral Anticoagulants.
    Tseng AS; Patel RD; Quist HE; Kekic A; Maddux JT; Grilli CB; Shamoun FE
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):121-126. PubMed ID: 29435777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders.
    Edris A; Callier E; Lahousse L
    BMC Med Genomics; 2022 Sep; 15(Suppl 3):193. PubMed ID: 36096833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the Impact of Sample Medication on Subsequent Patient Adherence.
    Pringle JL; Aldridge A; Kearney SM; Grasso K; Radack J; Hogue S; Manolis C
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1262-1269. PubMed ID: 27783544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of consent to pharmacogenomics testing in the IDEAL study.
    Jazwinski AB; Clark PJ; Thompson AJ; Gordon SC; Lawitz EJ; Noviello S; Brass CA; Pedicone LD; Albrecht JK; Sulkowski MS; Muir AJ
    Pharmacogenet Genomics; 2013 Nov; 23(11):619-23. PubMed ID: 24061202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
    Lee CR; Thomas CD; Beitelshees AL; Tuteja S; Empey PE; Lee JC; Limdi NA; Duarte JD; Skaar TC; Chen Y; Cook KJ; Coons JC; Dillon C; Franchi F; Giri J; Gong Y; Kreutz RP; McDonough CW; Stevenson JM; Weck KE; Angiolillo DJ; Johnson JA; Stouffer GA; Cavallari LH;
    Clin Pharmacol Ther; 2021 Mar; 109(3):705-715. PubMed ID: 32897581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenomics in general practice: The time has come.
    Polasek TM; Mina K; Suthers G
    Aust J Gen Pract; 2019 Mar; 48(3):100-105. PubMed ID: 31256470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
    Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
    Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts.
    Nguyen JQ; Crews KR; Moore BT; Kornegay NM; Baker DK; Hasan M; Campbell PK; Dean SM; Relling MV; Hoffman JM; Haidar CE
    J Am Med Inform Assoc; 2022 Dec; 30(1):132-138. PubMed ID: 36228116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System.
    Hui RL; Adams AL; Niu F; Ettinger B; Yi DK; Chandra M; Lo JC
    J Manag Care Spec Pharm; 2017 Apr; 23(4):503-512. PubMed ID: 28345435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenomic considerations for medications in the perioperative setting.
    Jhun EH; Apfelbaum JL; Dickerson DM; Shahul S; Knoebel R; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenomics; 2019 Jul; 20(11):813-827. PubMed ID: 31411557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule.
    Solomon DH; Brookhart MA; Tsao P; Sundaresan D; Andrade SE; Mazor K; Yood R
    Osteoporos Int; 2011 Jun; 22(6):1737-43. PubMed ID: 20878392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.